News

By ...

Biologics and biosimilars in Brazil – the strategic questions

Our partners Anderson Ribeiro, Aline Ferreira and Priscila Kashiwabara and patent specialist Marisa Momoli authored the chapter "Biologics and biosimilars in Brazil – the strategic questions". This article first appeared in IAM Life Sciences: Key issues for senior life sciences executives 2020, a supplement to IAM, published by Law Business Research – IP Division.
 
Click below to access the full chapter.
Back

Last by ...

July 5, 2021

Personalised medicine in Brazil: IP and regulatory challenges

Our partners Anderson Ribeiro, Aline Ferreira and Priscila Kashiwabara authored the chapter "Personalised medicine in Brazil: IP and regulatory challenges". This article first Personalised medicine in Brazil: IP and regulatory challenges

Ler notícia

June 24, 2021

Text of the Business Environment Bill is approved by the Chamber of Representatives, and it ends the prior approval for pharmaceutical patents, in addition to bringing relevant changes to trade names

Ler notícia

June 11, 2021

The first Action Plan for the implementation of the National Intellectual Property Strategy is approved

On June 9, 2021, the Interministerial Group on Industrial Property (GIPI, in the Portuguese acronym) approved the first Action Plan for the The first Action Plan for the implementation of the National Intellectual Property Strategy is approved

Ler notícia
plugins premium WordPress